A detailed history of Next Century Growth Investors LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Next Century Growth Investors LLC holds 293,608 shares of NEO stock, worth $4.14 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
293,608
Previous 293,380 0.08%
Holding current value
$4.14 Million
Previous $4.07 Million 6.41%
% of portfolio
0.39%
Previous 0.36%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.4 - $17.73 $3,055 - $4,042
228 Added 0.08%
293,608 $4.33 Million
Q2 2024

Aug 14, 2024

SELL
$13.01 - $15.77 $452,422 - $548,401
-34,775 Reduced 10.6%
293,380 $4.07 Million
Q1 2024

May 14, 2024

BUY
$14.06 - $16.79 $17,982 - $21,474
1,279 Added 0.39%
328,155 $5.16 Million
Q4 2023

Feb 14, 2024

BUY
$11.67 - $20.73 $1.14 Million - $2.03 Million
97,704 Added 42.63%
326,876 $5.29 Million
Q3 2023

Nov 14, 2023

BUY
$12.15 - $17.85 $2.78 Million - $4.09 Million
229,172 New
229,172 $2.82 Million
Q4 2021

Feb 14, 2022

SELL
$30.49 - $48.49 $3.46 Million - $5.51 Million
-113,593 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$41.66 - $52.52 $600,820 - $757,443
-14,422 Reduced 11.27%
113,593 $5.48 Million
Q2 2021

Aug 13, 2021

SELL
$36.62 - $51.69 $1.9 Million - $2.68 Million
-51,811 Reduced 28.81%
128,015 $5.78 Million
Q1 2021

May 14, 2021

SELL
$41.56 - $59.88 $3.73 Million - $5.37 Million
-89,735 Reduced 33.29%
179,826 $8.67 Million
Q4 2020

Feb 12, 2021

SELL
$36.08 - $56.47 $2.43 Million - $3.81 Million
-67,458 Reduced 20.02%
269,561 $14.5 Million
Q3 2020

Nov 13, 2020

SELL
$33.26 - $40.48 $1.73 Million - $2.11 Million
-52,017 Reduced 13.37%
337,019 $12.4 Million
Q2 2020

Aug 14, 2020

SELL
$24.21 - $31.02 $33,458 - $42,869
-1,382 Reduced 0.35%
389,036 $12.1 Million
Q1 2020

May 14, 2020

SELL
$20.5 - $34.53 $119,248 - $200,861
-5,817 Reduced 1.47%
390,418 $10.8 Million
Q4 2019

Feb 14, 2020

BUY
$18.96 - $29.84 $1.04 Million - $1.64 Million
54,886 Added 16.08%
396,235 $11.6 Million
Q3 2019

Nov 14, 2019

SELL
$19.12 - $26.24 $1.43 Million - $1.96 Million
-74,749 Reduced 17.96%
341,349 $6.53 Million
Q2 2019

Aug 14, 2019

BUY
$19.57 - $24.1 $2.24 Million - $2.76 Million
114,350 Added 37.9%
416,098 $9.13 Million
Q1 2019

May 14, 2019

SELL
$12.14 - $20.46 $446,169 - $751,945
-36,752 Reduced 10.86%
301,748 $6.17 Million
Q4 2018

Feb 14, 2019

BUY
$11.24 - $18.5 $3.8 Million - $6.26 Million
338,500 New
338,500 $4.27 Million
Q1 2018

May 14, 2018

SELL
$7.23 - $8.76 $7.66 Million - $9.28 Million
-1,059,767 Closed
0 $0
Q4 2017

Feb 13, 2018

SELL
$8.02 - $11.18 $7.26 Million - $10.1 Million
-905,209 Reduced 46.07%
1,059,767 $9.39 Million
Q3 2017

Nov 14, 2017

SELL
$9.11 - $11.26 $5.22 Million - $6.45 Million
-572,707 Reduced 22.57%
1,964,976 $21.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,537,683
2,537,683 $22.7 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.77B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Next Century Growth Investors LLC Portfolio

Follow Next Century Growth Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Next Century Growth Investors LLC with notifications on news.